Endocrinology Consultant spoke with Christian Hampp, PhD, from the US Food and Drug Administration, whose study found high rates of diabetic ketoacidosis when sodium-glucose cotransporter 2 inhibitors are...
Endocrinology Consultant spoke with James Rosenzweig, MD, chair of the task force that developed the Endocrine Society’s clinical practice guideline for the primary prevention of atherosclerotic...
New research suggests many older adults with type 2 diabetes believe factors including longer disease duration, more established complications, and more comorbidities warrant more aggressive diabetes...
Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
Consultant360 spoke with Blánaid Hicks, PhD, BSc, from Queen’s University Belfast, whose study found that the use of angiotensin converting enzyme inhibitors may be tied to an increased lung cancer risk...
New research presented at the American Society of Nephrology’s Kidney Week 2018 suggests that 2 key indicators of renal function may help assess the likelihood of experien
A new study has shown that adding sulfonylureas to first-line metformin treatment is likely a safer option than switching to sulfonylureas entirely in patients with type 2 diabetes. Consultant360 spoke with...
